News
Anne Wojcicki to buy back 23andMe and its data
Digest more
Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...
Former CEO Anne Wojcicki has prevailed in the bankruptcy auction of 23andMe, its consumer and biopharma research businesses, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results